Diskussionsleiter: H. Post (Berlin)
(P1378) | Economic Impact of Heart Failure with Preserved Ejection Fraction: Insights from the Prospective, Randomized Placebo-controlled Aldo-DHF Trial | |
D. Hashemi, L. Dettmann, H.-D. Düngen, T. D. Trippel, A. Bobenko, G. Gelbrich, R. Lindhorst, R. Wachter, G. Hasenfuß, B. Pieske, F. Edelmann (Berlin, Göttingen, Würzburg) | ||
(P1379) | Echocardiographic and clinical feature comparison in heart failure patients with mid-range and reduced ejection fraction: determinants of two-year survival | |
T. Kiwitz, D. Liu, K. Hu, K. Robitzkat, M. Schmidt, S. Herrmann, G. Ertl, S. Störk, P. Nordbeck (Würzburg) | ||
(P1380) | Presence of renal dysfunction is equally detrimental in heart failure patients with mid-range EF (HFmrEF) and with reduced EF (HFrEF) | |
K. Robitzkat, K. Hu, D. Liu, T. Kiwitz, M. Schmidt, S. Herrmann, C. Wanner, G. Ertl, S. Störk, P. Nordbeck (Würzburg) | ||
(P1381) | Non-invasive monitoring of peripheral and cardiac influence on exercise limitation in patients with heart failure with preserved ejection fraction | |
S. Beckmann, F. Weisrock, M. Fritschka, J. Wagner, E. Tahirovic, S. Radenovic, D. Hashemi, A. Busjahn, T. Krahn, W. Dinh, H.-D. Düngen (Berlin, Wuppertal) | ||
(P1382) | High intensity physical activity is related to maximal exercise performance in patients with heart failure with preserved ejection fraction | |
A. Bobenko, T. D. Trippel, R. Lindhorst, K. Nolte, I. Bartels, C. Herrmann-Lingen, M. Halle, A. Duvinage, H.-D. Düngen, G. Gelbrich, M. Münch, C. Tschöpe, G. Hasenfuß, R. Wachter, B. Pieske, F. Edelmann, KNHI, Aldo-DHF (Berlin, Göttingen, München, Würzburg) | ||
(P1383) | Test-retest-reliability of circulating endothelial and endothelial progenitor cells in peripheral blood in patients with heart failure, diabetic nephropathy and arterial hypertension | |
J. Wagner, M. Farinnaci, S. Beckmann, S. Litmeier, F. Weisrock, M. Fritschka, S. Radenovic, E. Tahirovic, D. Hashemi, W. Dinh, H.-D. Düngen (Berlin, Wuppertal) |